Bengaluru's Tricog Health Targets 10 Crore Cardiac Screenings by 2030

Bengaluru-based healthtech firm Tricog Health aims to conduct 100 million (10 crore) cardiac screenings by 2030, leveraging its AI-enabled ECG devices and specialist reviews. Since its inception in 2014, the company has already screened over 41 million patients across India and 14 other countries. This ambitious goal is set to significantly improve early detection and reduce diagnosis delays for cardiovascular diseases.

Bengaluru-based healthtech pioneer, Tricog Health, has announced an ambitious goal to perform 100 million, or 10 crore, cardiac screenings by the year 2030. This target underscores the company's commitment to significantly enhance preventive heart care, both within India and globally. The firm, founded in 2014, has already made substantial progress, having screened over 41 million patients for various heart conditions.

Under the leadership of CEO Dr. Charit Bhograj, Tricog Health has established itself as a frontrunner in utilising advanced technology for early disease detection. The core of its diagnostic approach lies in its proprietary AI-enabled Electrocardiogram (ECG) devices. These sophisticated devices are designed to quickly and accurately capture cardiac data, which is then analysed by artificial intelligence algorithms to identify potential anomalies.

Crucially, Tricog Health's methodology doesn't solely rely on AI. It integrates a vital human element by complementing AI analysis with reviews from a team of specialist doctors. This hybrid approach ensures a high degree of accuracy and reliability in diagnoses, combining the speed and efficiency of AI with the nuanced expertise of medical professionals. This dual-layered system is pivotal in ensuring that potential heart conditions are identified with precision.

The primary objective of Tricog Health's technology and expansive screening efforts is to address the critical challenges of diagnosis delays and improve the early detection of cardiovascular diseases (CVDs). Early diagnosis is paramount in managing heart conditions effectively, as it allows for timely intervention, lifestyle modifications, and treatment plans that can significantly improve patient outcomes and quality of life. By reducing the time taken for a diagnosis, Tricog aims to bridge a crucial gap in healthcare delivery, particularly in regions with limited access to specialised cardiology services.

Tricog Health's operations span across several states within India, demonstrating a strong focus on enhancing domestic healthcare infrastructure. Beyond national borders, the company has successfully extended its reach to 14 other countries, highlighting the global applicability and demand for its innovative cardiac screening solutions. This extensive footprint enables the firm to impact a diverse patient population, contributing to a broader public health benefit.

The target of 10 crore cardiac screenings by 2030 reflects a proactive strategy to combat the growing burden of heart-related ailments through accessible and technology-driven preventive care. It signals a future where advanced diagnostics are more readily available, empowering individuals to take informed steps towards maintaining their heart health.

This report is for informational purposes only and does not constitute medical or investment advice.